Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Analyst Recommendation

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Jul 16, 2017 12:32pm

169 Views

Post# 26474205

Analyst Recommendation

First stock in the clip. GLTA

https://www.bnn.ca/video/bob-mcwhirter-discusses-grande-west-transportation~1167807

2017-07-14 PAST TOP PICK Michael Smedley

(A Top Pick June 9/16. Up 6.9%.) He is very pleased with this because it has been underwater for a time. It has reconstituted itself with a management change at the top. It’s into infrastructure and electrical systems. Feels it is on the way to becoming something quite important, especially in the Northeast US where they bought a subsidiary a couple of years ago.

Login to show your approval Login to show your disapproval / Be the first to comment

Price:

$1.240

Subject:

CANADIAN

Bias:

UNKNOWN

Owned:

Yes

<< Previous

Bullboard Posts

Next >>